文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

[Evidence-based Chinese medicine:theory and practice].

作者信息

Zhang Jun-Hua, Li You-Ping, Zhang Bo-Li

机构信息

Institute of Chinese Medicine, Tianjin University of Traditional Chinses Medicine, Tianjin 300193, China.

Evidence-Based Medicine Center, Tianjin University of Traditional Chinses Medicine, Tianjin 300193, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2018 Jan;43(1):1-7. doi: 10.19540/j.cnki.cjcmm.20171127.001.


DOI:10.19540/j.cnki.cjcmm.20171127.001
PMID:29552804
Abstract

The introduction and popularization of evidence-based medicine has opened up a new research field of clinical efficacy evaluation of traditional Chinese medicine(TCM), produced new research ideas and methods, and promoted the progress of clinical research of TCM. After about 20 years assiduous study and earnest practice, the evidence based evaluation method and technique, which conforms to the characteristics of TCM theory and practice, has been developing continuously. Evidence-based Chinese medicine (EBCM) has gradually formed and become an important branch of evidence-based medicine. The basic concept of evidence-based Chinese medicine: EBCM is an applied discipline, following the theory and methodology of evidence-based medicine, to collect, evaluate, produce, transform the evidence of effectiveness, safety and economy of TCM, to reveal the feature and regular pattern of TCM taking effect, and to guide the development of clinical guidelines, clinical pathways and health decisions. The effects and achievements of EBCM development: secondary studies mainly based on systematic review/Meta-analysis were extensively carried out; clinical efficacy studies mainly relying on randomized controlled trials grew rapidly; clinical safety evaluations based on real world study have been conducted; methodological researches mainly focused on study quality control deepened gradually; internationalization researches mainly on report specifications have got some breakthroughs; standardization researches based on treatment specification were strengthened gradually; the research team and talents with the characteristics of inter-disciplinary have been steadily increased. A number of high-quality research findings have been published at international well-known journals; the clinical efficacy and safety evidence of TCM has been increased; the level of clinical rational use of TCM has been improved; a large number of Chinese patent medicines with big market have been cultured. The future missions of EBCM mainly consist of four categories (scientific research, methodology and standard, platform construction and personnel training) with nine tasks. ①Carry out systematic reviews to systematically collect clinical trial reports of TCM and establish database of clinical evidence of TCM; ②Carry out evidence transformation research to lay the foundation for the development of clinical diagnosis and treatment guidelines, clinical pathways of TCM, and for the screening of basic drug list and medical insurance list, and for the policy-making relevant to TCM; ③Conduct researches to evaluate the advantages and effective regular patterns of TCM and form the evidence chain of TCM efficacy; ④Carry out researches for the safety evaluation of TCM, and provide evidence supporting the rational and safe use of TCM in clinical practice; ⑤Conduct researches on methodology of EBCM and provide method for developing high quality evidence; ⑥Carry out researches to develop standards and norms of TCM, and to form methods, standards, specifications and technical systems; ⑦Establish data management platform for evidence-based evaluation of TCM, and promote data sharing; ⑧Build international academic exchange platform to promote international cooperation and mutual recognition of EBCM research; ⑨Carry out education and popularization activities of evidence-based evaluation methods, and train undergraduate students, graduate students, clinical healthcare providers and practitioners of TCM. The development of EBCM, as it was, not only promoted the transformation of clinical research and decision-making mode of TCM, contributed to the modernization and internationalization of TCM, but also enriched the connotation of Evidence-based Medicine.

摘要

相似文献

[1]
[Evidence-based Chinese medicine:theory and practice].

Zhongguo Zhong Yao Za Zhi. 2018-1

[2]
[Summary of development in scientific researches of traditional Chinese medicine in twenty years(1996-2015)].

Zhongguo Zhong Yao Za Zhi. 2016-11

[3]
[Theory of toxic classification of traditional Chinese medicine and recommendations for revision of China pharmacopeia (volume 1)].

Zhongguo Zhong Yao Za Zhi. 2012-8

[4]
[Development of clinical trial of new drugs of traditional Chinese medicines].

Zhongguo Zhong Yao Za Zhi. 2021-4

[5]
[Development and application of component-based Chinese medicine theory].

Zhongguo Zhong Yao Za Zhi. 2017-11

[6]
[Consideration on establishing evaluation system of clinical practice guidelines in traditional Chinese medicine].

Zhongguo Zhong Yao Za Zhi. 2020-4

[7]
[Exploration and practice of post-marketing survival benefit evaluation of Chinese patent medicine for cancer].

Zhongguo Zhong Yao Za Zhi. 2021-4

[8]
Oral traditional Chinese medication for adhesive small bowel obstruction.

Cochrane Database Syst Rev. 2012-5-16

[9]
Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional Chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews.

Trials. 2011-5-13

[10]
[Establishment of multiple evidence-integrated evaluation and prediction method for "toxic" Chinese medicines].

Zhongguo Zhong Yao Za Zhi. 2022-4

引用本文的文献

[1]
Clinical effect of Danshen decoction in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials.

PLoS One. 2023

[2]
Yinyanghuo () and its components for chronic obstructive pulmonary disease: preclinical evidence and possible mechanisms.

J Tradit Chin Med. 2023-4

[3]
Role of Alternative Medical Systems in Adult Chronic Kidney Disease Patients: A Systematic Review of Literature.

Cureus. 2022-12-23

[4]
Zhuanggu Guanjie herbal formula mitigates osteoarthritis the NF-κB transduction mechanism.

Front Pharmacol. 2022-12-1

[5]
Observational studies of traditional Chinese medicine may provide evidence nearly consistent with the randomized controlled trials: A meta-epidemiological study.

Integr Med Res. 2022-12

[6]
Research Trends of Systematic Review/Meta-Analysis on Acupuncture Therapy: A Bibliometric Analysis.

J Pain Res. 2021-2-26

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索